Homologous recombination deficiency and host anti-tumor immunity in triple-negative breast cancer.
M L TelliDaniel G StoverS LoiS AparicioL A CareyS M DomchekL NewmanG W SledgeE P WinerPublished in: Breast cancer research and treatment (2018)
HR deficiency remains an important biomarker target and potentially effective adjunct to enhance immunogenicity of 'immune cold' TNBCs.